• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Eichhorst B, Dreyling M, Robak T, Montserrat E, Hallek M

机构信息

Klinik I für Innere Medizin, Universität zu Köln, Köln, Germany.

出版信息

Ann Oncol. 2011 Sep;22 Suppl 6:vi50-4. doi: 10.1093/annonc/mdr377.

DOI:10.1093/annonc/mdr377
PMID:21908504
Abstract
摘要

相似文献

1
Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi50-4. doi: 10.1093/annonc/mdr377.
2
Chronic lymphocytic leukemia: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：欧洲肿瘤内科学会关于诊断、治疗及随访的最低临床建议
Ann Oncol. 2009 May;20 Suppl 4:102-4. doi: 10.1093/annonc/mdp142.
3
Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii60-2. doi: 10.1093/annonc/mdn090.
4
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Jan;32(1):23-33. doi: 10.1016/j.annonc.2020.09.019. Epub 2020 Oct 19.
5
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v162-4. doi: 10.1093/annonc/mdq180.
6
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v78-84. doi: 10.1093/annonc/mdv303.
7
[The guidelines for diagnosis and treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma in China （2015 edition）].中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤诊断与治疗指南（2015年版）
Zhonghua Xue Ye Xue Za Zhi. 2015 Oct;36(10):809-13. doi: 10.3760/cma.j.issn.0253-2727.2015.10.001.
8
Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide.共识声明强调了在全球范围内协调慢性淋巴细胞白血病管理的必要性。
Acta Haematol. 2024;147(3):257-259. doi: 10.1159/000533349. Epub 2023 Aug 7.
9
[Chinese guidelines for the diagnosis and management of chronic lymphocytic leukemia (2011)].[中国慢性淋巴细胞白血病诊断与治疗指南（2011年版）]
Zhonghua Xue Ye Xue Za Zhi. 2011 Jul;32(7):498-501.
10
Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2007 Apr;18 Suppl 2:ii49-50. doi: 10.1093/annonc/mdm034.

引用本文的文献

1
Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance.继发性低丙种球蛋白血症：具有临床重要性的儿科疾病的诊断与管理。
Curr Opin Pediatr. 2024 Dec 1;36(6):659-667. doi: 10.1097/MOP.0000000000001396. Epub 2024 Sep 2.
2
Characterization of Three Somatic Mutations in the 3'UTR of and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia.鉴定 3'UTR 中三个体细胞突变及其与慢性淋巴细胞白血病淋巴细胞增多的反向相关性。
Cells. 2023 Nov 22;12(23):2687. doi: 10.3390/cells12232687.
3
Role of microRNAs in Chronic Lymphocytic Leukemia.
微小 RNA 在慢性淋巴细胞白血病中的作用。
Int J Mol Sci. 2023 Aug 5;24(15):12471. doi: 10.3390/ijms241512471.
4
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia.治疗初治慢性淋巴细胞白血病的治疗方法选择中存在的未解决问题。
J Hematol Oncol. 2023 Jul 8;16(1):72. doi: 10.1186/s13045-023-01469-7.
5
Cooperatively enhanced photothermal-chemotherapy simultaneously downregulating HSPs and promoting DNA alkylation in cancer cells.协同增强的光热化疗可同时下调癌细胞中的热休克蛋白并促进DNA烷基化。
Chem Sci. 2022 Dec 28;14(4):1010-1017. doi: 10.1039/d2sc06143k. eCollection 2023 Jan 25.
6
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia.采用流式细胞免疫表型分析实施国际预后指数，以更好地对慢性淋巴细胞白血病进行风险分层。
Eur J Haematol. 2022 Nov;109(5):483-493. doi: 10.1111/ejh.13833. Epub 2022 Aug 1.
7
Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment.评价单次剂量阿卡替尼在肝损伤受试者中的药代动力学和安全性。
J Clin Pharmacol. 2022 Jun;62(6):812-822. doi: 10.1002/jcph.2013. Epub 2022 Feb 15.
8
Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility.苯达莫司汀即用型产品对美国一家输液机构治疗慢性淋巴细胞白血病和非霍奇金淋巴瘤的预算影响。
Clinicoecon Outcomes Res. 2021 Mar 22;13:201-211. doi: 10.2147/CEOR.S297284. eCollection 2021.
9
Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review.TP53基因缺陷型慢性淋巴细胞白血病患者的治疗选择：叙述性综述
Cancer Manag Res. 2021 Feb 12;13:1459-1476. doi: 10.2147/CMAR.S283903. eCollection 2021.
10
Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish experts.以抗体缺陷为主的继发性免疫缺陷：波兰专家的多学科观点
Cent Eur J Immunol. 2020;45(3):334-341. doi: 10.5114/ceji.2020.101265. Epub 2020 Nov 1.